Article
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum.
Lung cancer (Amsterdam, Netherlands) - 1 Apr 2018
Liao Wei-Yu, Ho Chao-Chi, Tsai Tzu-Hsiu, Chen Kuan-Yu, Shih Jin-Yuan, Yu Chong-Jen
Abstract excerpt
OBJECTIVES: Polymorphisms of DNA repair genes may affect DNA repair capacity and the sensitivity of platinum doublets chemotherapy in non-small-cell lung cancer (NSCLC). We prospectively evaluated whether single nucleotide polymorphisms (SNPs) of ERCC1, ERCC2, XRCC1, and XRCC3 were associated with treatment outcome in advanced non-squamous NSCLC patients receiving pemetrexed/platinum as their first-line...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
